Second allogeneic hematopoietic cell transplantation enables long-term disease-free survival in relapsed acute leukemia
C Schneidawind, V Hagmaier, C Faul, L Kanz… - Annals of …, 2018 - Springer
… acute myeloid leukemia (AML) and acute lymphoblastic leukemia (… disease relapse since
we excluded graft failure as indication … , and time from transplant to full donor chimerism had no …
we excluded graft failure as indication … , and time from transplant to full donor chimerism had no …
Impact on outcomes of mixed chimerism of bone marrow CD34+ sorted cells after matched or haploidentical allogeneic stem cell transplantation for myeloid …
Y Le Bris, D Costes, R Bourgade, T Guillaume… - … Marrow Transplantation, 2022 - nature.com
… be monitored by assessing the chimerism of donor (D) and … in about two thirds of acute
myeloid leukemia (AML) patients [… for acute or chronic myeloid disease, between October 2009 …
myeloid leukemia (AML) patients [… for acute or chronic myeloid disease, between October 2009 …
… Blood CD34 Donor Chimerism has Greater Clinical Utility Than CD3 for Detecting Relapse after Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or …
TP Das, D North, SA Fleming, JLC Tan, A Ivey… - Transplantation and …, 2023 - Elsevier
… In July 2011, the Alfred Hospital Bone Marrow Transplantation Service … Overall survival and
relapse-free survival (RFS) were … the CD34 + DC sample to measure NPM1 mut , a molecular …
relapse-free survival (RFS) were … the CD34 + DC sample to measure NPM1 mut , a molecular …
[HTML][HTML] Allogeneic hematopoietic cell transplantation in multiple myeloma: focus on longitudinal assessment of donor chimerism, extramedullary disease, and high …
… the impact of several other disease- and treatment-related … was associated with shorter
progression-free survival (PFS) (… the post-transplantation period is the analysis of the donor …
progression-free survival (PFS) (… the post-transplantation period is the analysis of the donor …
Very early lineage-specific chimerism after reduced intensity stem cell transplantation is highly predictive of clinical outcome for patients with myeloid disease
FAM Kinsella, CF Inman, A Gudger, YT Chan… - Leukemia research, 2019 - Elsevier
… and T-cell donor chimerism 50 days after transplantation and … risk of disease relapse and
a reduction in relapse-free survival [8]. … predictor of full donor status at day 50. Recipient/…
a reduction in relapse-free survival [8]. … predictor of full donor status at day 50. Recipient/…
… graft‐versus‐host‐disease‐free event‐free survival in Fanconi anaemia patients undergoing matched related‐ and unrelated‐donor bone marrow transplantation …
F Bernard, CRS Uppugunduri, S Meyer… - British Journal of …, 2021 - Wiley Online Library
… malignancies, especially acute myeloid leukaemia (AML) and … neutrophil recovery with
donor chimaerism was achieved … an indication to transplant but no available matched donor. …
donor chimaerism was achieved … an indication to transplant but no available matched donor. …
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: the role of the conditioning regimen
P Chiusolo, S Bregante, S Giammarco… - American Journal of …, 2021 - Wiley Online Library
… 14 : in this report the progression free survival at 1 year was … , declining bone marrow
chimerism, a bone marrow biopsy … predictor of full donor chimerism on day +30, was donor type: …
chimerism, a bone marrow biopsy … predictor of full donor chimerism on day +30, was donor type: …
[HTML][HTML] Chimerism in the realm of hematopoietic stem cell transplantation for non-malignant disorders—a perspective
C Zimmerman, S Shenoy - Frontiers in immunology, 2020 - frontiersin.org
… In general, a rapid drop of donor chimerism early post-HCT is … in predicting 5-year event-free
survival (EFS). It was higher in … post-HCT, a measure of blood brain barrier recovery (19). …
survival (EFS). It was higher in … post-HCT, a measure of blood brain barrier recovery (19). …
[HTML][HTML] Mixed myeloid chimerism and relapse of myelofibrosis after allogeneic stem cell transplantation
SA Srour, A Olsonr, SO Ciurear, P Desair… - …, 2021 - ncbi.nlm.nih.gov
… Secondary end points were the progression- free survival (PFS) … progressive loss of donor
myeloid chimerism and graft failure… predicts clinical relapse of chronic myeloid leukemia but is …
myeloid chimerism and graft failure… predicts clinical relapse of chronic myeloid leukemia but is …
Chimerism analysis for clinicians: a review of the literature and worldwide practices
AG Blouin, M Askar - Bone marrow transplantation, 2022 - nature.com
… primary indication for chimerism testing… donor chimerism (CC) within 30 days after allogeneic
HCT was associated with both lower probability of relapse and longer relapse free survival (…
HCT was associated with both lower probability of relapse and longer relapse free survival (…